Penumbra, Inc Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Penumbra, Inc (PEN) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $1.30 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-07-30
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-06-30 was $819.00K, a 58.55% decline year-over-year.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $486.00K, a 42.00% decline year-over-year.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-12-31 was $6.55M, a 1366.00% increase year-over-year.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $145.00K, a 86.54% decline year-over-year.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $9.51M, a 298.32% increase from fiscal 2024.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $2.39M, a 74.43% decline from fiscal 2023.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $9.34M, a 87.08% decline from fiscal 2022.
- Penumbra, Inc right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $72.28M, a 28.80% decline from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $819.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $1.30M 10-Q · filed 2026-07-30 | $7.86M derived: sum of 3 quarters · filed 2026-07-30 | $8.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $486.00K 10-Q · filed 2026-05-06 | $7.04M derived: sum of 2 quarters · filed 2026-05-06 | $7.18M derived: sum of 3 quarters · filed 2026-05-06 | $9.16M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $6.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.70M derived: sum of 2 quarters · filed 2026-02-25 | $8.67M derived: sum of 3 quarters · filed 2026-07-30 | $9.51M 10-K · filed 2026-02-25 |
| 2025-09-30 | $145.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $2.12M derived: sum of 2 quarters · filed 2026-07-30 | $2.96M 10-Q · filed 2025-11-05 | $3.41M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $1.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.81M 10-Q · filed 2026-07-30 | $3.26M derived: sum of 3 quarters · filed 2026-07-30 | $4.34M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $838.00K 10-Q · filed 2026-05-06 | $1.28M derived: sum of 2 quarters · filed 2026-05-06 | $2.36M derived: sum of 3 quarters · filed 2026-05-06 | $2.93M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.52M derived: sum of 2 quarters · filed 2026-02-25 | $2.10M derived: sum of 3 quarters · filed 2026-02-25 | $2.39M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.65M derived: sum of 2 quarters · filed 2025-11-05 | $1.94M 10-Q · filed 2025-11-05 | $9.79M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $572.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $864.00K 10-Q · filed 2025-07-29 | $8.72M derived: sum of 3 quarters · filed 2026-02-25 | $9.05M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $292.00K 10-Q · filed 2025-04-23 | $8.14M derived: sum of 2 quarters · filed 2026-02-25 | $8.48M derived: sum of 3 quarters · filed 2026-02-25 | $9.29M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $7.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $8.18M derived: sum of 2 quarters · filed 2026-02-25 | $9.00M derived: sum of 3 quarters · filed 2026-02-25 | $9.34M 10-K · filed 2026-02-25 |
| 2023-09-30 | $331.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | $1.15M derived: sum of 2 quarters · filed 2024-10-30 | $1.49M 10-Q · filed 2024-10-30 | $22.27M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-06-30 | $814.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30 | $1.16M 10-Q · filed 2024-07-30 | $21.94M derived: sum of 3 quarters · filed 2025-02-18 | $22.24M derived: sum of 4 quarters · filed 2025-02-18 |
| 2023-03-31 | $341.00K 10-Q · filed 2024-05-07 | $21.13M derived: sum of 2 quarters · filed 2025-02-18 | $21.43M derived: sum of 3 quarters · filed 2025-02-18 | $24.94M derived: sum of 4 quarters · filed 2025-02-18 |
| 2022-12-31 | $20.78M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $21.09M derived: sum of 2 quarters · filed 2025-02-18 | $24.60M derived: sum of 3 quarters · filed 2025-02-18 | $72.28M 10-K · filed 2025-02-18 |
| 2022-09-30 | $304.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $3.82M derived: sum of 2 quarters · filed 2023-11-02 | $51.49M 10-Q · filed 2023-11-02 | $52.83M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $51.19M 10-Q · filed 2023-08-01 | $52.52M derived: sum of 3 quarters · filed 2024-02-22 | $98.26M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $47.68M 10-Q · filed 2023-05-02 | $49.01M derived: sum of 2 quarters · filed 2024-02-22 | $94.74M derived: sum of 3 quarters · filed 2024-02-22 | $148.38M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $47.07M derived: sum of 2 quarters · filed 2024-02-22 | $100.71M derived: sum of 3 quarters · filed 2024-02-22 | $101.51M 10-K · filed 2024-02-22 |
| 2021-09-30 | $45.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $99.38M derived: sum of 2 quarters · filed 2022-11-03 | $100.18M 10-Q · filed 2022-11-03 | $100.61M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $53.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $54.44M 10-Q · filed 2022-08-05 | $54.87M derived: sum of 3 quarters · filed 2023-02-23 | $55.13M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $803.00K 10-Q · filed 2022-05-03 | $1.23M derived: sum of 2 quarters · filed 2023-02-23 | $1.49M derived: sum of 3 quarters · filed 2023-02-23 | $1.99M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $685.00K derived: sum of 2 quarters · filed 2023-02-23 | $1.19M derived: sum of 3 quarters · filed 2023-02-23 | $1.51M 10-K · filed 2023-02-23 |
| 2020-09-30 | $256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $761.00K derived: sum of 2 quarters · filed 2021-11-03 | $1.09M 10-Q · filed 2021-11-03 | $3.61M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-06-30 | $505.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $830.00K 10-Q · filed 2021-08-09 | $3.35M derived: sum of 3 quarters · filed 2022-02-22 | $3.98M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-03-31 | $325.00K 10-Q · filed 2021-05-04 | $2.85M derived: sum of 2 quarters · filed 2022-02-22 | $3.48M derived: sum of 3 quarters · filed 2022-02-22 | $4.49M derived: sum of 4 quarters · filed 2022-02-22 |
| 2019-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $3.15M derived: sum of 2 quarters · filed 2022-02-22 | $4.17M derived: sum of 3 quarters · filed 2022-02-22 | $4.26M 10-K · filed 2022-02-22 |
| 2019-09-30 | $627.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $1.64M derived: sum of 2 quarters · filed 2020-11-02 | $1.74M 10-Q · filed 2020-11-02 | |
| 2019-06-30 | $1.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-03 | $1.11M 10-Q · filed 2020-08-03 | ||
| 2019-03-31 | $94.00K 10-Q · filed 2020-05-07 | |||
| 2018-06-30 | $1.11M 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |